p63 and p73 in human cancer: defining the network (Q36749787)

16 August 2017

1 reference

title

p63 and p73 in human cancer: defining the network (English)

1 reference

16 August 2017

M P Deyoung

1

1 reference

PubMed ID

17334395

16 August 2017

L W Ellisen

series ordinal

2

1 reference

PubMed ID

17334395

16 August 2017

language of work or name

English

0 references

publication date

5 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

26

1 reference

16 August 2017

5169-5183

1 reference

16 August 2017

36

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210337

16 August 2017

0 references

cites work

p73 and p63: why do we still need them?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

DeltaN-p73alpha accumulates in human neuroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

Itch/AIP4 associates with and promotes p63 protein degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

Loss of p63 expression is associated with tumor progression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

DeltaNp63alpha levels correlate with clinical tumor response to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Mdm2 binds p73 alpha without targeting degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 and epithelial biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Induction of p57(KIP2) expression by p73beta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 isoforms can regulate p53 transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 family members in myogenic differentiation and rhabdomyosarcoma development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 regulates an adhesion programme and cell survival in epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

How many mutant p53 molecules are needed to inactivate a tetramer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 protein variants: structural and functional similarities with p63 and p73 isoforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Allelic expression and quantitative RT-PCR study of TAp73 and DeltaNp73 in non-Hodgkin's lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Evolution of functions within the p53/p63/p73 family.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 and p73 transactivate differentiation gene promoters in human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Wild type p73 overexpression and high-grade malignancy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

E1A activates transcription of p73 and Noxa to induce apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

RETRACTED: p73alpha regulation by Chk1 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Marker succession during the development of keratinocytes from cultured human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Positive and negative regulation of ΔN-p63 promoter activity by p53 and ΔN-p63-α contributes to differential regulation of p53 target genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The common and distinct target genes of the p53 family transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

AIS is an oncogene amplified in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Elevated expression of p63 protein in human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Role for the p53 homologue p73 in E2F-1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Chemosensitivity linked to p73 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 is an essential proapoptotic protein during neural development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p19ras interacts with and activates p73 by involving the MDM2 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The expression of p73, p21 and MDM2 proteins in gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 deficiency activates a program of cellular senescence and leads to accelerated aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

P73 status in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

DeltaNp73beta is active in transactivation and growth suppression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Expression of deltaNp73 and TAp73alpha independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

DNA damage induces the rapid and selective degradation of the DeltaNp73 isoform, allowing apoptosis to occur.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Pin1 links the activities of c-Abl and p300 in regulating p73 function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73: Friend or foe in tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Functional regulation of p73 and p63: development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63: oncogene or tumor suppressor?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 is a p53 homologue required for limb and epidermal morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

MDM2--master regulator of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 Homologue p63 represses epidermal growth factor receptor expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Differential expression of p63 isoforms in normal tissues and neoplastic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Regulation of the p73 protein stability and degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Association of p63 with proliferative potential in normal and neoplastic human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

DeltaNp63 induces beta-catenin nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

An anti-apoptotic role for the p53 family member, p73, during developmental neuron death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: Potential roles for Sp1/Sp3, NF-Y, and p63.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The E3 ubiquitin ligase Itch controls the protein stability of p63

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The ubiquitin-protein ligase Itch regulates p73 stability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The human p73 promoter: characterization and identification of functional E2F binding sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 and p73 are not required for the development and p53-dependent apoptosis of T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Dominant negative p63 isoform expression in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Role of p73 in malignancy: tumor suppressor or oncogene?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 protects the female germ line during meiotic arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 Family members p63 and p73 are SAM domain-containing proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The expression of p73 is increased in lung cancer, independent of p53 gene alteration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

High-resolution genomic profiles of human lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 regulates proliferation and differentiation of developmentally mature keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p53 mutant mice that display early ageing-associated phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

1 reference

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

1 reference

7 January 2021

Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Differential regulation of p63 and p73 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 expression in normal, hyperplastic and malignant breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Ubiquitin and ubiquitin-like modifications of the p53 family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

P63 and P73: P53 mimics, menaces and more

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

On the shoulders of giants: p63, p73 and the rise of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210337

7 January 2021

WITHDRAWN: Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus☆,☆☆

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.BBRC.2005.08.084

Identifiers

DOI

10.1038/SJ.ONC.1210337

1 reference

16 August 2017

1 reference

PubMed ID

17334395